about
Imaging findings and therapy response monitoring in chronic sclerodermatous graft-versus-host disease: preliminary data of a simultaneous PET/MRI approach.Improving CT-Based PET Attenuation Correction in the Vicinity of Metal Implants by an Iterative Metal Artifact Reduction Algorithm of CT Data and Its Comparison to Dual-Energy-Based Strategies: A Phantom Study.Improved detection of splenosis in patients with haematological disorders: the role of combined transmission-emission tomography.SUV-quantification of physiological lung tissue in an integrated PET/MR-system: Impact of lung density and bone tissue.Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.Impact of age on the relationships of brown adipose tissue with sex and adiposity in humansCombined PET/MR imaging using (68)Ga-DOTATOC for radiotherapy treatment planning in meningioma patients.Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?Multimodal imaging approaches: PET/CT and PET/MRI.[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.Image-derived biomarkers and multimodal imaging strategies for lung cancer management.Segmentation-based attenuation correction in positron emission tomography/magnetic resonance: erroneous tissue identification and its impact on positron emission tomography interpretation.Impact of 18F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysis.Significance of the "halo" sign for progression and regression of nodular pulmonary amyloidosis: radiographic-pathological correlation (2005:6b).Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.Comparison of Positron Emission Tomography Quantification Using Magnetic Resonance- and Computed Tomography-Based Attenuation Correction in Physiological Tissues and Lesions: A Whole-Body Positron Emission Tomography/Magnetic Resonance Study in 66 PPatient comfort during positron emission tomography/magnetic resonance and positron emission tomography/computed tomography examinations: subjective assessments with visual analog scales.Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT.PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors?Presumed tuberculosis-induced retinal vasculitis, diagnosed with positron emission tomography (18F-FDG-PET/CT), aspiration biopsy, and culture.Somatostatin receptor expression in an epitheloid hemangioma causing oncogenic osteomalacia.Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET/CT imaging.Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.Diffusion tensor imaging in a human PET/MR hybrid system.(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer--initial results.Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer.
P50
Q30596475-54DF85D9-581D-4152-91A5-73E58D8DC945Q31114685-DC6D3B95-2B9E-4B9A-A77A-282BBC3AF096Q33346262-F7BB69A6-2F85-4673-92E6-7D01A2851D9AQ33745862-FBB4FF2D-85BC-4ED0-AC69-D1773C7C355FQ33814088-CBE899D1-111B-4E81-A6B9-D795747B4EE8Q33930310-C774AC9A-403F-47E2-A7B9-FF101FA10A4CQ34392384-B6CC37F7-F86A-4CD5-A86F-DC4E1E040C80Q36243671-9A0FF0AF-E995-4302-929E-61EC0514A107Q37216466-F7CE68E5-F0AB-4B92-8893-2C09E8029E30Q37448735-B70DCCB8-1E6E-4408-BF47-486926BAC797Q38312373-C0BF5F11-5CBD-4392-AF4D-BB8A183CD338Q38317009-BCBDAED8-5B56-440F-B743-699E9083CCA3Q40286525-075F211A-62E0-44FB-A088-E80DDFEAE889Q40387987-36769892-C1F9-4B1E-8AA3-C789DCD91773Q40524925-0736266E-2FD3-46AB-BDB5-19511E63298FQ40563411-8F50B5CD-75CF-4DA3-83BB-5F39C4611CFCQ40873271-C43045E4-EB5C-4655-95BB-5FC9CC0666DBQ42957425-C78F6364-EFE3-4D55-BDE4-D2DF73C5DBC1Q43059550-30460CDB-BB46-4161-A394-037A57283C4EQ43060162-8BEC449A-4794-402A-81FB-232E95C01057Q43269547-4148BE2D-14AF-463E-A001-3202514A6A41Q43988491-87C44D41-60EF-4E43-805D-B8152E62A00AQ43993837-218CB308-05BA-47CB-8647-015A1E1189D0Q44076876-4595A175-BF4B-451C-BD6E-67C1CC15129AQ46055368-8A145B14-0B28-46CD-81BC-8BFFE06DC8D0Q46104163-8EF3E9A7-095C-48E2-A89C-EB2D96086BB4Q46634592-9E066200-5214-4CA2-9B26-F0E0F1619BEAQ46730564-6226DD9C-4E07-44A3-A4CC-9F7BA320C7B5
P50
name
Christina Pfannenberg
@ast
Christina Pfannenberg
@en
Christina Pfannenberg
@es
Christina Pfannenberg
@fr
Christina Pfannenberg
@nl
type
label
Christina Pfannenberg
@ast
Christina Pfannenberg
@en
Christina Pfannenberg
@es
Christina Pfannenberg
@fr
Christina Pfannenberg
@nl
prefLabel
Christina Pfannenberg
@ast
Christina Pfannenberg
@en
Christina Pfannenberg
@es
Christina Pfannenberg
@fr
Christina Pfannenberg
@nl